• Je něco špatně v tomto záznamu ?

Prolonged Corrected QT Interval as a Predictor of Clinical Outcome in Acute Ischemic Stroke

M. Hromádka, J. Seidlerová, V. Rohan, J. Baxa, J. Šedivý, D. Rajdl, I. Ulč, P. Ševčík, J. Polívka, R. Rokyta,

. 2016 ; 25 (12) : 2911-2917. [pub] 20160908

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17023707

BACKGROUND: This study aimed to investigate changes of corrected QT (QTc) interval during acute ischemic stroke and its correlation with high-sensitivity troponin I (hsTnI), brain natriuretic peptide (BNP), neurological outcome, and 1-year mortality. METHODS: We registered electrocardiogram in 69 patients immediately after admission to the intensive care unit and then after 24 and 48 hours. Computed tomography was performed on admission to determine brain infarct size and localization. Neurological outcome was assessed by modified Rankin scale (mRS) at discharge. RESULTS: Forty-five (65.2%) patients had prolonged QTc at baseline; only 18 (26.1%) patients had prolonged QTc after 48 hours. Baseline QTc was not associated with neurological outcome (P = .27). However, prolonged QTc after 48 hours was associated with worse mRS at discharge (4.5 [4.0-6.0] versus 2.0 [1.0-3.0]; P < .0001). Patients who deceased during hospitalization (n = 7 [10.1%]) as compared with survivors had more frequently prolonged QTc after 48 hours (38.9 versus 0%; P < .0001), higher level of hsTnI (48.4 [36.1-75.0] versus 8.6 [3.4-26.5]; P = .003), and BNP (334 [224-866] versus 109 [30-190]; P = .014). In univariate analysis, 1-year mortality was associated with prolonged QTc after 48 hours, hsTnI, and BNP. In multivariate analysis, only BNP remained to be associated with 1-year mortality (odds ratio 3.41, 95% confidence interval 1.06-11.03). CONCLUSIONS: QTc interval in patients with acute ischemic stroke is a dynamic parameter. Prolonged QTc after 48 hours, but not baseline QTc, correlated with neurological outcome and 1-year mortality. Patients with prolonged QTc had higher level of hsTnI.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023707
003      
CZ-PrNML
005      
20170720122322.0
007      
ta
008      
170720s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jstrokecerebrovasdis.2016.08.005 $2 doi
035    __
$a (PubMed)27618199
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Hromádka, Milan $u Cardiology Department, Faculty of Medicine in Pilsen and Faculty Hospital, Charles University, Czech Republic.
245    10
$a Prolonged Corrected QT Interval as a Predictor of Clinical Outcome in Acute Ischemic Stroke / $c M. Hromádka, J. Seidlerová, V. Rohan, J. Baxa, J. Šedivý, D. Rajdl, I. Ulč, P. Ševčík, J. Polívka, R. Rokyta,
520    9_
$a BACKGROUND: This study aimed to investigate changes of corrected QT (QTc) interval during acute ischemic stroke and its correlation with high-sensitivity troponin I (hsTnI), brain natriuretic peptide (BNP), neurological outcome, and 1-year mortality. METHODS: We registered electrocardiogram in 69 patients immediately after admission to the intensive care unit and then after 24 and 48 hours. Computed tomography was performed on admission to determine brain infarct size and localization. Neurological outcome was assessed by modified Rankin scale (mRS) at discharge. RESULTS: Forty-five (65.2%) patients had prolonged QTc at baseline; only 18 (26.1%) patients had prolonged QTc after 48 hours. Baseline QTc was not associated with neurological outcome (P = .27). However, prolonged QTc after 48 hours was associated with worse mRS at discharge (4.5 [4.0-6.0] versus 2.0 [1.0-3.0]; P < .0001). Patients who deceased during hospitalization (n = 7 [10.1%]) as compared with survivors had more frequently prolonged QTc after 48 hours (38.9 versus 0%; P < .0001), higher level of hsTnI (48.4 [36.1-75.0] versus 8.6 [3.4-26.5]; P = .003), and BNP (334 [224-866] versus 109 [30-190]; P = .014). In univariate analysis, 1-year mortality was associated with prolonged QTc after 48 hours, hsTnI, and BNP. In multivariate analysis, only BNP remained to be associated with 1-year mortality (odds ratio 3.41, 95% confidence interval 1.06-11.03). CONCLUSIONS: QTc interval in patients with acute ischemic stroke is a dynamic parameter. Prolonged QTc after 48 hours, but not baseline QTc, correlated with neurological outcome and 1-year mortality. Patients with prolonged QTc had higher level of hsTnI.
650    _2
$a akční potenciály $7 D000200
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a ischemie mozku $x diagnóza $x mortalita $x patofyziologie $x terapie $7 D002545
650    _2
$a mozková angiografie $x metody $7 D002533
650    _2
$a CT angiografie $7 D000072226
650    _2
$a posuzování pracovní neschopnosti $7 D004185
650    12
$a elektrokardiografie $7 D004562
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a převodní systém srdeční $x patofyziologie $7 D006329
650    12
$a srdeční frekvence $7 D006339
650    _2
$a mortalita v nemocnicích $7 D017052
650    _2
$a lidé $7 D006801
650    _2
$a jednotky intenzivní péče $7 D007362
650    _2
$a logistické modely $7 D016015
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a multivariační analýza $7 D015999
650    _2
$a natriuretický peptid typu B $x krev $7 D020097
650    _2
$a neurologické vyšetření $7 D009460
650    _2
$a odds ratio $7 D016017
650    _2
$a příjem pacientů $7 D010343
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a obnova funkce $7 D020127
650    _2
$a rizikové faktory $7 D012307
650    _2
$a cévní mozková příhoda $x diagnóza $x mortalita $x patofyziologie $x terapie $7 D020521
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
650    _2
$a troponin I $x krev $7 D019210
655    _2
$a časopisecké články $7 D016428
700    1_
$a Seidlerová, Jitka $u Internal Department II, Faculty of Medicine in Pilsen, Charles University, Czech Republic; Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Czech Republic. Electronic address: seidlerovaji@fnplzen.cz.
700    1_
$a Rohan, Vladimír $u Neurology Department, Faculty of Medicine in Pilsen, Charles University, Czech Republic.
700    1_
$a Baxa, Jan $u Department of Imaging Methods, Faculty of Medicine in Pilsen, Charles University, Czech Republic.
700    1_
$a Šedivý, Jakub $u Cardiology Department, Faculty of Medicine in Pilsen and Faculty Hospital, Charles University, Czech Republic.
700    1_
$a Rajdl, Daniel $u Department of Clinical Biochemistry and Hematology, Faculty Hospital in Pilsen, Czech Republic.
700    1_
$a Ulč, Ivan $u Cardiology Department, Faculty of Medicine in Pilsen and Faculty Hospital, Charles University, Czech Republic.
700    1_
$a Ševčík, Petr $u Neurology Department, Faculty of Medicine in Pilsen, Charles University, Czech Republic.
700    1_
$a Polívka, Jiří $u Neurology Department, Faculty of Medicine in Pilsen, Charles University, Czech Republic.
700    1_
$a Rokyta, Richard $u Cardiology Department, Faculty of Medicine in Pilsen and Faculty Hospital, Charles University, Czech Republic.
773    0_
$w MED00167194 $t Journal of stroke and cerebrovascular diseases the official journal of National Stroke Association $x 1532-8511 $g Roč. 25, č. 12 (2016), s. 2911-2917
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27618199 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170720122815 $b ABA008
999    __
$a ok $b bmc $g 1239388 $s 984620
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 25 $c 12 $d 2911-2917 $e 20160908 $i 1532-8511 $m Journal of stroke and cerebrovascular diseases $n J Stroke Cerebrovasc Dis $x MED00167194
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Možnosti archivace